Over the past decades, accumulating research has noted the cytotoxic functions of CD4+ T cells in cancers (8–10, 37), which displayed heterogeneous phenotypes with functional capacity of direct tumor lysis through MHC class II-dependent pathways. The gene discussed is CD4; the disease is cancer.